These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 25036057

  • 1. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
    Runkle I, Villabona C, Navarro A, Pose A, Formiga F, Tejedor A, Poch E.
    Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057
    [Abstract] [Full Text] [Related]

  • 2. [The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
    Runkle I, Villabona C, Navarro A, Pose A, Formiga F, Tejedor A, Poch E, European Hyponatremia Network.
    Med Clin (Barc); 2013 Dec 07; 141(11):507.e1-507.e10. PubMed ID: 24169317
    [Abstract] [Full Text] [Related]

  • 3. 'Dos and don'ts' in the management of hyponatremia.
    Aylwin S, Burst V, Peri A, Runkle I, Thatcher N.
    Curr Med Res Opin; 2015 Dec 07; 31(9):1755-61. PubMed ID: 26173050
    [Abstract] [Full Text] [Related]

  • 4. [Hyponatremia in older persons (II)-A clear treatment : How to detect tricks and avoid pitfalls].
    Hofmann W, Flägel K, Gosch M.
    Z Gerontol Geriatr; 2020 Aug 07; 53(5):463-472. PubMed ID: 32691149
    [Abstract] [Full Text] [Related]

  • 5. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
    Ramamohan V, Mladsi D, Ronquest N, Kamat S, Boklage S.
    Hosp Pract (1995); 2017 Aug 07; 45(3):111-117. PubMed ID: 28449624
    [Abstract] [Full Text] [Related]

  • 6. Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
    Peri A, Giuliani C.
    Minerva Endocrinol; 2014 Mar 07; 39(1):33-41. PubMed ID: 24513602
    [Abstract] [Full Text] [Related]

  • 7. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G, Tessaris D, Einaudi S, De Sanctis L, Matarazzo P.
    J Clin Res Pediatr Endocrinol; 2017 Sep 01; 9(3):288-292. PubMed ID: 28515029
    [Abstract] [Full Text] [Related]

  • 8. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH, Bohm NM, Nemecek BD, Crawford R, Kelley D, Bhasin B, Nietert PJ, Velez JCQ.
    Am J Kidney Dis; 2018 Jun 01; 71(6):772-782. PubMed ID: 29478867
    [Abstract] [Full Text] [Related]

  • 9. SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
    De Las Peñas R, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Álvarez Y, Rodríguez CA, Virizuela JA, López López R.
    Support Care Cancer; 2016 Jan 01; 24(1):499-507. PubMed ID: 26431960
    [Abstract] [Full Text] [Related]

  • 10. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
    Chen S, Zhao JJ, Tong NW, Guo XH, Qiu MC, Yang GY, Liu ZM, Ma JH, Zhang ZW, Gu F.
    J Clin Pharmacol; 2014 Dec 01; 54(12):1362-7. PubMed ID: 24906029
    [Abstract] [Full Text] [Related]

  • 11. [Severe hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone].
    Foppiani L, Raggi F, Tagliabue M, Benso A, Brandolin I, Lo Pinto G.
    Recenti Prog Med; 2013 Mar 01; 104(3):112-5. PubMed ID: 23548955
    [Abstract] [Full Text] [Related]

  • 12. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
    Mali P, Muduganti SR, Mujibur R, Murali N.
    WMJ; 2015 Apr 01; 114(2):66-8. PubMed ID: 26756059
    [Abstract] [Full Text] [Related]

  • 13. [Etiology, diagnostics and therapy of hyponatremias].
    Laczi F.
    Orv Hetil; 2008 Jul 20; 149(29):1347-54. PubMed ID: 18617466
    [Abstract] [Full Text] [Related]

  • 14. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Gralla RJ, Ahmad F, Blais JD, Chiodo J, Zhou W, Glaser LA, Czerwiec FS.
    Cancer Med; 2017 Apr 20; 6(4):723-729. PubMed ID: 28251822
    [Abstract] [Full Text] [Related]

  • 15. Hyponatremia in cancer patients.
    Platania M, Verzoni E, Vitali M.
    Tumori; 2015 Apr 20; 101(2):246-8. PubMed ID: 25908038
    [Abstract] [Full Text] [Related]

  • 16. [Hyponatremia : The water-intolerant patient].
    Hensen J.
    Med Klin Intensivmed Notfmed; 2012 Sep 20; 107(6):440-7. PubMed ID: 22911166
    [Abstract] [Full Text] [Related]

  • 17. Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
    Han SW, Yi JH, Kang KP, Kim HY, Kim SW, Choi HY, Ha SK, Kim GH, Kim YW, Jeong KH, Shin SK, Kim HJ.
    J Korean Med Sci; 2018 Apr 09; 33(15):e112. PubMed ID: 29629516
    [Abstract] [Full Text] [Related]

  • 18. Electrolytes: Sodium Disorders.
    Braun MM, Mahowald M.
    FP Essent; 2017 Aug 09; 459():11-20. PubMed ID: 28806046
    [Abstract] [Full Text] [Related]

  • 19. [Syndrome of inadequate ADH secretion: pitfalls in diagnosis and therapy].
    Schäffler A, Lindner U.
    Dtsch Med Wochenschr; 2015 Mar 09; 140(5):343-6. PubMed ID: 25734677
    [Abstract] [Full Text] [Related]

  • 20. The syndrome of inappropriate antidiuretic hormone: current and future management options.
    Sherlock M, Thompson CJ.
    Eur J Endocrinol; 2010 Jun 09; 162 Suppl 1():S13-8. PubMed ID: 20164215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.